Vildan Akgül

 

 

Holds a BSc degree in Genetic and Bioengineering from Fatih University in 2012.

She is 2nd year MSc student of Pharmaceutical Toxicology in Marmara University where she worked on the CYP2C9 enzyme’s polymorphism in Turkish population as her master thesis.

She has worked in the project titled as “Study of the potential genotoxicity risk for the health care workers that has had occupational exposure of anti-neoplastic agent”.

She is interested in Pharmacogenetics, Genotoxicology, Biosimilars, Pharmacovigilance, Individualized Drug Therapy and Stem Cell.

She is currently working as a bioengineer in the Regenerative and Restorative Research Center.